Imprimis' Fight Against Martin Shkreli Is Part Of A Larger Battle http://www.forbes.com/sites/davidkroll/2015/10/23/imiprimis-ceo-on-compounding-a-low-cost-alternative-to-turings-daraprim-for-toxoplasmosis/?utm_campaign=forbeshealth&utm_source=TWITTER&utm_medium=social&utm_channel=Business&linkId=18211025 KBIO